51 related articles for article (PubMed ID: 16253774)
1. Economic consequence of local control with radiotherapy: cost analysis of internal mammary and medial supraclavicular lymph node radiotherapy in breast cancer.
Lievens Y; Kesteloot K; van den Bogaert W
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1122-31. PubMed ID: 16253774
[TBL] [Abstract][Full Text] [Related]
2. CHART in lung cancer: economic evaluation and incentives for implementation.
Lievens Y; Kesteloot K; Van den Bogaert W
Radiother Oncol; 2005 May; 75(2):171-8. PubMed ID: 15878631
[TBL] [Abstract][Full Text] [Related]
3. Quality assurance in breast cancer: EORTC experiences in the phase III trial on irradiation of the internal mammary nodes.
Musat E; Poortmans P; Van den Bogaert W; Struikmans H; Fourquet A; Bartelink H; Kirkove C; Budach V; Pierart M; Collette L
Eur J Cancer; 2007 Mar; 43(4):718-24. PubMed ID: 17240136
[TBL] [Abstract][Full Text] [Related]
4. Interpreting the economic literature in oncology.
Grusenmeyer PA; Wong YN
J Clin Oncol; 2007 Jan; 25(2):196-202. PubMed ID: 17210940
[TBL] [Abstract][Full Text] [Related]
5. Model to assess the cost-effectiveness of new treatments for depression.
Sobocki P; Ekman M; Agren H; Jönsson B; Rehnberg C
Int J Technol Assess Health Care; 2006; 22(4):469-77. PubMed ID: 16984680
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of new breast cancer radiotherapy technologies in diverse populations.
Gold HT; Hayes MK
Breast Cancer Res Treat; 2012 Nov; 136(1):221-9. PubMed ID: 22983837
[TBL] [Abstract][Full Text] [Related]
7. Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis.
Jewell EL; Kulasingam S; Myers ER; Alvarez Secord A; Havrilesky LJ
Gynecol Oncol; 2007 Dec; 107(3):532-40. PubMed ID: 17900674
[TBL] [Abstract][Full Text] [Related]
8. DEGRO practical guidelines for radiotherapy of breast cancer II. Postmastectomy radiotherapy, irradiation of regional lymphatics, and treatment of locally advanced disease.
Sautter-Bihl ML; Souchon R; Budach W; Sedlmayer F; Feyer P; Harms W; Haase W; Dunst J; Wenz F; Sauer R
Strahlenther Onkol; 2008 Jul; 184(7):347-53. PubMed ID: 19016032
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of letrozole in the extended adjuvant treatment of women with early breast cancer.
El Ouagari K; Karnon J; Delea T; Talbot W; Brandman J
Breast Cancer Res Treat; 2007 Jan; 101(1):37-49. PubMed ID: 16821085
[TBL] [Abstract][Full Text] [Related]
11. Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer: an economic analysis based on prognostic and predictive validation studies.
Lyman GH; Cosler LE; Kuderer NM; Hornberger J
Cancer; 2007 Mar; 109(6):1011-8. PubMed ID: 17311307
[TBL] [Abstract][Full Text] [Related]
12. Postmastectomy radiotherapy in intermediate risk stage I-II breast cancer patients.
Mladenovic J; Susnjar S; Gavrilovic D; Borojevic N
J BUON; 2007; 12(2):215-20. PubMed ID: 17600875
[TBL] [Abstract][Full Text] [Related]
13. Regional nodal recurrence in breast cancer patients treated with conservative surgery and radiation therapy (BCS+RT).
Pejavar S; Wilson LD; Haffty BG
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1320-7. PubMed ID: 17049182
[TBL] [Abstract][Full Text] [Related]
14. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091
[TBL] [Abstract][Full Text] [Related]
15. The cost of radiotherapy in a decade of technology evolution.
Van de Werf E; Verstraete J; Lievens Y
Radiother Oncol; 2012 Jan; 102(1):148-53. PubMed ID: 21872955
[TBL] [Abstract][Full Text] [Related]
16. Partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer: a cost-effectiveness analysis.
Sher DJ; Wittenberg E; Suh WW; Taghian AG; Punglia RS
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):440-6. PubMed ID: 18963542
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: a health-economic model simulation based on a patient survey and clinical trial data.
Hjelmgren J; Svensson A; Jörgensen ET; Lindemalm-Lundstam B; Ragnarson Tennvall G
Br J Dermatol; 2007 May; 156(5):913-21. PubMed ID: 17263826
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of group psychotherapy for depression in Uganda.
Siskind D; Baingana F; Kim J
J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
[TBL] [Abstract][Full Text] [Related]
19. Modeling the cost-effectiveness of a new treatment for MS (natalizumab) compared with current standard practice in Sweden.
Kobelt G; Berg J; Lindgren P; Jonsson B; Stawiarz L; Hillert J
Mult Scler; 2008 Jun; 14(5):679-90. PubMed ID: 18566030
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]